← brief for 2026-08-20 · Slowing decline

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Key takeaways

A trial of finenorme in children with CKD and proteinuria. The study will enroll 50 patients over 18 months.

Who did this work

Run by Bayer.
Sites: Lucille Packard Children's Hospital Stanford - Pediatric Nephrology · Rady Children's Hospital San Diego - Cardiology · Children's National Hospital - Nephrology · Memorial Transplant Institute - Pediatric Nephrology · University of Iowa Health Care Medical Center - Nephrology · The Charlotte R. Bloomberg Children's Center Building - Nephrology

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-20
https://clinicaltrials.gov/study/NCT05457283